Lifecore Biomedical, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Lifecore Biomedical, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than 98% of Healthcare companies in United States.
- Growth Efficiency Ratio: Sales grew 16% in 3 years; of every extra $100 of sales, $443 became extra profit. Higher than 92% of Healthcare companies in United States.
- Cash Cushion Ratio: Debt, after subtracting cash, equals 51% of its market value (net debt). Lower than 92% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (May 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-0.3×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Higher than 63% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
$443Sales grew 16% in 3 years; of every extra $100 of sales, $443 became extra profit.
Higher than 92% of Healthcare companies in United States.
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-0.1×Operating cash was negative last year, while some debt falls due within a year.
Higher than 68% of Healthcare companies in United States.
Cash Cushion Ratio
−51%Debt, after subtracting cash, equals 51% of its market value (net debt).
Lower than 92% of Healthcare companies in United States.
Tangible Assets Ratio
94%Of every $100 the company owns, $94 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 70% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 98% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (7)
Lifecore Biomedical, Inc. made a loss over the last year. Lifecore Biomedical, Inc. owes $1.15 for every $1 it owns.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossLifecore Biomedical, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
-7.08Lifecore Biomedical, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$241 MThe total market value of all of Lifecore Biomedical, Inc.'s shares at today's price (share price × number of shares), smaller than 55% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
NegativeLifecore Biomedical, Inc.'s net worth is negative ($34 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
1.15×Lifecore Biomedical, Inc. owes $1.15 for every $1 it owns, so it owes more than it owns, higher than 90% of Healthcare companies in United States.
Dividend yield
NoneLifecore Biomedical, Inc. does not currently pay a dividend.
Cash vs debt
Net debtLifecore Biomedical, Inc. had $125 M more debt than cash (net debt) at Dec 2025.
Questions
How much does Lifecore Biomedical, Inc. owe compared with what it owns?
Lifecore Biomedical, Inc. owes $1.15 for every $1 it owns, so it owes more than it owns, higher than 90% of Healthcare companies in United States.
Does Lifecore Biomedical, Inc. pay a dividend?
No. Lifecore Biomedical, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.